Tumor mutational burden predicts progression-free survival and local-regional control in locally advanced non-small cell lung cancer patients treated with chemoradiation and durvalumab Meeting Abstract


Authors: Shaverdian, N.; Shepherd, A. F.; Offin, M.; Gelblum, D.; Wu, A. J.; Simone, C. B. 2nd; Schoenfeld, A. J.; Jones, D.; Rimner, A.; Chaft, J.; Riaz, N.; Gomez, D. R.
Abstract Title: Tumor mutational burden predicts progression-free survival and local-regional control in locally advanced non-small cell lung cancer patients treated with chemoradiation and durvalumab
Meeting Title: 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2022)
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 114
Issue: 3 Suppl.
Meeting Dates: 2022 Oct 23-26
Meeting Location: Virtual
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2022-11-01
Start Page: e390
End Page: e391
Language: English
DOI: 10.1016/j.ijrobp.2022.07.1546
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting abstracts: 2873 -- In section "Poster Q & A Sessions" -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daphna Y Gelblum
    227 Gelblum
  2. Nadeem Riaz
    415 Riaz
  3. Daniel R Gomez
    237 Gomez
  4. Jamie Erin Chaft
    289 Chaft
  5. Andreas Rimner
    524 Rimner
  6. Abraham Jing-Ching Wu
    400 Wu
  7. David Randolph Jones
    417 Jones
  8. Michael David Offin
    170 Offin
  9. Annemarie Fernandes Shepherd
    103 Shepherd